On "A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants" (Am J Perinatol 2004;21:109-120).
作者信息
Bancalari Eduardo
出版信息
Am J Perinatol. 2004 Jul;21(5):307-9. doi: 10.1055/s-2004-829876.
PMID:15232767
Abstract
摘要
相似文献
1
On "A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants" (Am J Perinatol 2004;21:109-120).
Am J Perinatol. 2004 Jul;21(5):307-9. doi: 10.1055/s-2004-829876.
2
A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants.
Am J Perinatol. 2004 Apr;21(3):109-19. doi: 10.1055/s-2004-823779.
3
Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome.
J Perinatol. 2010 Oct;30(10):665-70. doi: 10.1038/jp.2010.20. Epub 2010 Mar 25.
4
Poractant alfa versus beractant for respiratory distress syndrome in preterm infants: a retrospective cohort study.
J Paediatr Child Health. 2013 Oct;49(10):839-44. doi: 10.1111/jpc.12300. Epub 2013 Jun 26.
5
Patent ductus arteriosus hemodynamics in very premature infants treated with poractant alfa or beractant for respiratory distress syndrome.
J Perinatol. 2010 Oct;30(10):671-6. doi: 10.1038/jp.2010.21. Epub 2010 Mar 25.
6
Poractant alfa versus beractant in the treatment of preterm infants with respiratory distress syndrome.
J Paediatr Child Health. 2013 Dec;49(12):1084. doi: 10.1111/jpc.12439.
7
In response to mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractant: a retrospective study.
J Perinatol. 2013 Feb;33(2):165-6. doi: 10.1038/jp.2012.163.
8
Complications among premature neonates treated with beractant and poractant alfa.
Indian J Pediatr. 2010 Jul;77(7):751-4. doi: 10.1007/s12098-010-0097-y. Epub 2010 Jun 29.
9
A randomized, controlled trial of poractant alfa versus beractant in the treatment of preterm infants with respiratory distress syndrome.
Am J Perinatol. 2012 Feb;29(2):95-100. doi: 10.1055/s-0031-1295648. Epub 2011 Nov 21.
10
A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
Pediatrics. 2005 Apr;115(4):1030-8. doi: 10.1542/peds.2004-2231.
Zotero 插件